{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:14:27Z","timestamp":1794276867417,"version":"4.9.0"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008397","name":"Velux Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.neurobiolaging.2019.05.003","type":"journal-article","created":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T10:45:51Z","timestamp":1557744351000},"page":"88-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Short erythropoietin-derived peptide enhances memory, improves long-term potentiation, and counteracts amyloid beta\u2013induced pathology"],"prefix":"10.1016","volume":"81","author":[{"given":"Oksana","family":"Dmytriyeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amor","family":"Belmeguenai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Bezin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Soud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Paul","family":"Drucker Woldbye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casper Ren\u00e9","family":"G\u00f8tzsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5406-5163","authenticated-orcid":false,"given":"Stanislava","family":"Pankratova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1741-7007-6-37","article-title":"Erythropoietin enhances hippocampal long-term potentiation and memory","volume":"6","author":"Adamcio","year":"2008","journal-title":"BMC Biol."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib2","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/syn.21895","article-title":"EPO induces changes in synaptic transmission and plasticity in the dentate gyrus of rats","volume":"70","author":"Almaguer-Melian","year":"2016","journal-title":"Synapse"},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4103\/2277-9175.100157","article-title":"Erythropoietin improves neuronal proliferation in dentate gyrus of hippocampal formation in an animal model of Alzheimer's disease","volume":"1","author":"Arabpoor","year":"2012","journal-title":"Adv. Biomed. Res."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3233\/JAD-141389","article-title":"Memory improvement in the AbetaPP\/PS1 mouse model of familial Alzheimer's disease induced by carbamylated-erythropoietin is accompanied by modulation of synaptic genes","volume":"45","author":"Armand-Ugon","year":"2015","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/nen.0b013e3180517b28","article-title":"Brain erythropoietin receptor expression in Alzheimer disease and mild cognitive impairment","volume":"66","author":"Assaraf","year":"2007","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib6","doi-asserted-by":"crossref","first-page":"762","DOI":"10.3109\/00207454.2013.878935","article-title":"Erythropoietin pretreatment suppresses seizures and prevents the increase in inflammatory mediators during pentylenetetrazole-induced generalized seizures","volume":"124","author":"Bahcekapili","year":"2014","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.trsl.2013.12.008","article-title":"Erythropoietin prevents cognitive impairment and oxidative parameters in Wistar rats subjected to pneumococcal meningitis","volume":"163","author":"Barichello","year":"2014","journal-title":"Transl Res."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib8","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/0891988709332939","article-title":"Impaired social cognition in mild Alzheimer disease","volume":"22","author":"Bediou","year":"2009","journal-title":"J.\u00a0Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/0891988717743587","article-title":"The relationship between social cognition and awareness in Alzheimer disease","volume":"31","author":"Belfort","year":"2018","journal-title":"J.\u00a0Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib10","doi-asserted-by":"crossref","first-page":"13630","DOI":"10.1523\/JNEUROSCI.3226-10.2010","article-title":"Intrinsic plasticity complements long-term potentiation in parallel fiber input gain control in cerebellar Purkinje cells","volume":"30","author":"Belmeguenai","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib11","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3389\/fnins.2017.00672","article-title":"Loss of neuroprotective factors in neurodegenerative dementias: the end or the starting point?","volume":"11","author":"Benussi","year":"2017","journal-title":"Front Neurosci."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/361031a0","article-title":"A\u00a0synaptic model of memory: long-term potentiation in the hippocampus","volume":"361","author":"Bliss","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib13","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3389\/fimmu.2014.00523","article-title":"Evidence that erythropoietin modulates Neuroinflammation through differential action on neurons, astrocytes, and microglia","volume":"5","author":"Bond","year":"2014","journal-title":"Front Immunol."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib14","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1038\/s41598-017-03167-0","article-title":"EV-3, an endogenous human erythropoietin isoform with distinct functional relevance","volume":"7","author":"Bonnas","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib15","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrn1687","article-title":"Emerging biological roles for erythropoietin in the nervous system","volume":"6","author":"Brines","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib16","doi-asserted-by":"crossref","first-page":"10526","DOI":"10.1073\/pnas.97.19.10526","article-title":"Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury","volume":"97","author":"Brines","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib17","doi-asserted-by":"crossref","first-page":"14907","DOI":"10.1073\/pnas.0406491101","article-title":"Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor","volume":"101","author":"Brines","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib18","doi-asserted-by":"crossref","first-page":"10925","DOI":"10.1073\/pnas.0805594105","article-title":"Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin","volume":"105","author":"Brines","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neuron.2004.09.006","article-title":"Memory and executive function in aging and AD: multiple factors that cause decline and reserve factors that compensate","volume":"44","author":"Buckner","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2040-7378-1-4","article-title":"Erythropoietin: a multimodal neuroprotective agent","volume":"1","author":"Byts","year":"2009","journal-title":"Exp. Transl Stroke Med."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/hipo.450030208","article-title":"An examination of the relations between hippocampal long-term potentiation, kindling, afterdischarge, and place learning in the water maze","volume":"3","author":"Cain","year":"1993","journal-title":"Hippocampus"},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib22","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1073\/pnas.042693799","article-title":"Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury","volume":"99","author":"Celik","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib23","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.euroneuro.2015.09.005","article-title":"Testing the antidepressant properties of the peptide ARA290 in a human neuropsychological model of drug action","volume":"25","author":"Cerit","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib24","doi-asserted-by":"crossref","first-page":"12457","DOI":"10.1038\/s41598-018-29865-x","article-title":"EPO does not promote interaction between the erythropoietin and beta-common receptors","volume":"8","author":"Cheung Tung Shing","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib25","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2174\/156720205774962683","article-title":"Erythropoietin requires NF-kappaB and its nuclear translocation to prevent early and late apoptotic neuronal injury during beta-amyloid toxicity","volume":"2","author":"Chong","year":"2005","journal-title":"Curr. Neurovasc Res."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib26","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1111\/j.1528-1167.2008.01644.x","article-title":"Erythropoietin reduces epileptogenic processes following status epilepticus","volume":"49","author":"Chu","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.brainres.2004.05.078","article-title":"Age-related changes in erythropoietin immunoreactivity in the cerebral cortex and hippocampus of rats","volume":"1018","author":"Chung","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib28","doi-asserted-by":"crossref","first-page":"e71479","DOI":"10.1371\/journal.pone.0071479","article-title":"Amyloid-beta induced CA1 pyramidal cell loss in young adult rats is alleviated by systemic treatment with FGL, a neural cell adhesion molecule-derived mimetic peptide","volume":"8","author":"Corbett","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pneurobio.2012.07.001","article-title":"Brain excitability and connectivity of neuronal assemblies in Alzheimer's disease: from animal models to human findings","volume":"99","author":"D'Amelio","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib30","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1038\/cdd.2009.95","article-title":"Survival, neuron-like differentiation and functionality of mesenchymal stem cells in neurotoxic environment: the critical role of erythropoietin","volume":"16","author":"Danielyan","year":"2009","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(96)00922-3","article-title":"In\u00a0vitro aggregation facilities beta-amyloid peptide-(25-35)-induced amnesia in the rat","volume":"319","author":"Delobette","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib32","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/gbb.12001","article-title":"A\u00a0single intramuscular injection of rAAV-mediated mutant erythropoietin protects against MPTP-induced parkinsonism","volume":"12","author":"Dhanushkodi","year":"2013","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib33","doi-asserted-by":"crossref","first-page":"1346390","DOI":"10.1155\/2016\/1346390","article-title":"Epobis is a nonerythropoietic and neuroprotective agonist of the erythropoietin receptor with anti-inflammatory and memory enhancing effects","volume":"2016","author":"Dmytriyeva","year":"2016","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib34","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.mp.4001442","article-title":"Erythropoietin: a candidate compound for neuroprotection in schizophrenia","volume":"9","author":"Ehrenreich","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib35","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/sj.mp.4001907","article-title":"Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin","volume":"12","author":"Ehrenreich","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1741-7007-7-37","article-title":"Erythropoietin improves operant conditioning and stability of cognitive performance in mice","volume":"7","author":"El-Kordi","year":"2009","journal-title":"BMC Biol."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib37","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.nbd.2012.07.016","article-title":"Neuroprotective and memory enhancing properties of a dual agonist of the FGF receptor and NCAM","volume":"48","author":"Enevoldsen","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib38","doi-asserted-by":"crossref","first-page":"6741","DOI":"10.1073\/pnas.1031753100","article-title":"Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in\u00a0vivo","volume":"100","author":"Erbayraktar","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pbb.2014.12.011","article-title":"Erythropoietin improves synaptic plasticity and memory deficits by decrease of the neurotransmitter release probability in the rat model of Alzheimer's disease","volume":"130","author":"Esmaeili Tazangi","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib40","doi-asserted-by":"crossref","first-page":"e53888","DOI":"10.1371\/journal.pone.0053888","article-title":"Standardized environmental enrichment supports enhanced brain plasticity in healthy rats and prevents cognitive impairment in epileptic rats","volume":"8","author":"Fares","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib41","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.biopha.2016.08.065","article-title":"Ropren(R) treatment reverses anxiety-like behavior and monoamines levels in gonadectomized rat model of Alzheimer's disease","volume":"83","author":"Fedotova","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib42","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/SLA.0000000000002142","article-title":"Erythropoietin to reduce mortality in traumatic brain injury: a post-hoc dose-effect analysis","volume":"267","author":"Gantner","year":"2017","journal-title":"Ann. Surg."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib43","doi-asserted-by":"crossref","first-page":"E4914","DOI":"10.1073\/pnas.1609883113","article-title":"I.\u00a0Major neurotransmitter systems in dorsal hippocampus and basolateral amygdala control social recognition memory","volume":"113","author":"Garrido Zinn","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib44","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/ki.1990.229","article-title":"Improvement of brain function in hemodialysis patients treated with erythropoietin","volume":"38","author":"Grimm","year":"1990","journal-title":"Kidney Int."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib45","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.expneurol.2007.06.021","article-title":"Behavioral alterations in the pilocarpine model of temporal lobe epilepsy in mice","volume":"207","author":"Groticke","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib46","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1699-0463.1988.tb00954.x","article-title":"The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis","volume":"96","author":"Gundersen","year":"1988","journal-title":"APMIS"},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib47","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1182\/blood.V90.5.1867","article-title":"The beta chain of the interleukin-3 receptor functionally associates with the erythropoietin receptor","volume":"90","author":"Jubinsky","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib48","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.brainres.2009.05.062","article-title":"Erythropoietin pre-treatment prevents cognitive impairments following status epilepticus in rats","volume":"1282","author":"Jun","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib49","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.brainres.2011.06.059","article-title":"Erythropoietin decreases the excitatory neurotransmitter release probability and enhances synaptic plasticity in mice hippocampal slices","volume":"1410","author":"Kamal","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib50","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/ndt\/13.1.229","article-title":"Recombinant erythropoietin improves cognitive function in chronic haemodialysis patients","volume":"13","author":"Kambova","year":"1998","journal-title":"Nephrol. Dial Transplant."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib51","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.neuroscience.2006.11.060","article-title":"A\u00a0neural cell adhesion molecule-derived peptide reduces neuropathological signs and cognitive impairment induced by Abeta25-35","volume":"145","author":"Klementiev","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib52","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1742-2094-11-27","article-title":"Anti-inflammatory properties of a novel peptide interleukin 1 receptor antagonist","volume":"11","author":"Klementiev","year":"2014","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib53","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6","article-title":"Long-term memory underlying hippocampus-dependent social recognition in mice","volume":"10","author":"Kogan","year":"2000","journal-title":"Hippocampus"},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib54","doi-asserted-by":"crossref","first-page":"e59672","DOI":"10.1371\/journal.pone.0059672","article-title":"Influence of erythropoietin on cognitive performance during experimental hypoglycemia in patients with type 1 diabetes mellitus: a randomized cross-over trial","volume":"8","author":"Kristensen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib55","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bbr.2003.11.002","article-title":"Erythropoietin improves long-term spatial memory deficits and brain injury following neonatal hypoxia-ischemia in rats","volume":"153","author":"Kumral","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib56","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1471-4159.2011.07534.x","article-title":"Erythropoietin improves memory function with reducing endothelial dysfunction and amyloid-beta burden in Alzheimer\u2019s disease models","volume":"120","author":"Lee","year":"2012","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib57","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1126\/science.1098313","article-title":"Derivatives of erythropoietin that are tissue protective but not erythropoietic","volume":"305","author":"Leist","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib58","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/ana.20274","article-title":"Beneficial effect of erythropoietin on experimental allergic encephalomyelitis","volume":"56","author":"Li","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib59","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.exger.2016.07.012","article-title":"Oxidative stress induces the decline of brain EPO expression in aging rats","volume":"83","author":"Li","year":"2016","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib60","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.clineuro.2016.09.001","article-title":"Recombinant human erythropoietin improves functional recovery in patients with severe traumatic brain injury: a randomized, double blind and controlled clinical trial","volume":"150","author":"Li","year":"2016","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib61","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bbr.2017.01.045","article-title":"Dopamine and dopamine receptor D1 associated with decreased social interaction","volume":"324","author":"Liu","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib62","doi-asserted-by":"crossref","first-page":"e77182","DOI":"10.1371\/journal.pone.0077182","article-title":"Age-dependent astroglial vulnerability to hypoxia and glutamate: the role for erythropoietin","volume":"8","author":"Lourhmati","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib63","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1089\/neu.2005.22.1011","article-title":"Erythropoietin enhances neurogenesis and restores spatial memory in rats after traumatic brain injury","volume":"22","author":"Lu","year":"2005","journal-title":"J.\u00a0Neurotrauma"},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib64","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.neuropharm.2009.02.006","article-title":"Erythropoietin protects PC12 cells from beta-amyloid(25-35)-induced apoptosis via PI3K\/Akt signaling pathway","volume":"56","author":"Ma","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib65","doi-asserted-by":"crossref","first-page":"11102","DOI":"10.3390\/ijms130911102","article-title":"Erythropoietin: new directions for the nervous system","volume":"13","author":"Maiese","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib66","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1177\/0269881113494939","article-title":"Intranasal formulation of erythropoietin (EPO) showed potent protective activity against amyloid toxicity in the Abeta(2)(5)(-)(3)(5) non-transgenic mouse model of Alzheimer's disease","volume":"27","author":"Maurice","year":"2013","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2009.04.007","article-title":"Epilepsy, psychosocial and cognitive functioning","volume":"86","author":"McCagh","year":"2009","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib68","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.brainresrev.2010.06.004","article-title":"Neurite outgrowth: this process, first discovered by Santiago Ramon y Cajal, is sustained by the exocytosis of two distinct types of vesicles","volume":"66","author":"Meldolesi","year":"2011","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib69","doi-asserted-by":"crossref","first-page":"776","DOI":"10.2174\/1381612822666161206141744","article-title":"Neurodegenerative disease: a perspective on cell-based therapy in the new era of cell-free Nano-therapy","volume":"23","author":"Metcalfe","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib70","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1523\/JNEUROSCI.5013-06.2007","article-title":"Erythropoietin enhances hippocampal response during memory retrieval in humans","volume":"27","author":"Miskowiak","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib71","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00221-007-1102-1","article-title":"Differential effects of erythropoietin on neural and cognitive measures of executive function 3 and 7 days post-administration","volume":"184","author":"Miskowiak","year":"2008","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib72","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/sj.npp.1301439","article-title":"Erythropoietin improves mood and modulates the cognitive and neural processing of emotion 3 days post administration","volume":"33","author":"Miskowiak","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib73","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00213-011-2511-1","article-title":"Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression","volume":"219","author":"Miskowiak","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib74","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.4088\/JCP.13m08839","article-title":"Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial","volume":"75","author":"Miskowiak","year":"2014","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib75","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bbr.2007.08.009","article-title":"Erythropoietin improves spatial delayed alternation in a T-maze in fimbria-fornix transected rats","volume":"186","author":"Mogensen","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib76","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0306-4522(96)00306-5","article-title":"Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in\u00a0vitro glutamate-induced neuronal death","volume":"76","author":"Morishita","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib77","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejphar.2009.07.020","article-title":"Pilocarpine vs. lithium-pilocarpine for induction of status epilepticus in mice: development of spontaneous seizures, behavioral alterations and neuronal damage","volume":"619","author":"Muller","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib78","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.nbd.2006.10.009","article-title":"Neuroprotective effects of erythropoietin in the rat hippocampus after pilocarpine-induced status epilepticus","volume":"25","author":"Nadam","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib79","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neulet.2010.12.025","article-title":"Recombinant human erythropoietin prevents motor neuron apoptosis in a rat model of cervical sub-acute spinal cord compression","volume":"490","author":"Ning","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib80","article-title":"Alternative erythropoietin receptors in the nervous system","volume":"7","author":"Ostrowski","year":"2018","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib81","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2119\/molmed.2015.00192","article-title":"Widespread expression of erythropoietin receptor in brain and its induction by injury","volume":"21","author":"Ott","year":"2015","journal-title":"Mol. Med."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib82","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/brain\/awq101","article-title":"Neuroprotective properties of a novel, non-haematopoietic agonist of the erythropoietin receptor","volume":"133","author":"Pankratova","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib83","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1471-4159.2012.07751.x","article-title":"A\u00a0new agonist of the erythropoietin receptor, Epobis, induces neurite outgrowth and promotes neuronal survival","volume":"121","author":"Pankratova","year":"2012","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib84","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/S0272-6386(99)70150-2","article-title":"Normalizing hematocrit in dialysis patients improves brain function","volume":"33","author":"Pickett","year":"1999","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib85","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1089\/neu.2012.2431","article-title":"Treatment of mild traumatic brain injury with an erythropoietin-mimetic peptide","volume":"30","author":"Robertson","year":"2013","journal-title":"J.\u00a0Neurotrauma"},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib86","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3233\/JAD-160500","article-title":"An intranasal formulation of erythropoietin (Neuro-EPO) prevents memory deficits and amyloid toxicity in the APPSwe transgenic mouse model of Alzheimer's disease","volume":"55","author":"Rodriguez Cruz","year":"2017","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib87","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neures.2010.05.002","article-title":"Effects of FGF receptor peptide agonists on animal behavior under normal and pathological conditions","volume":"68","author":"Rudenko","year":"2010","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib88","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1073\/pnas.95.8.4635","article-title":"In\u00a0vivo evidence that erythropoietin protects neurons from ischemic damage","volume":"95","author":"Sakanaka","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib89","doi-asserted-by":"crossref","first-page":"9848","DOI":"10.1073\/pnas.0901840106","article-title":"Optimal neuroprotection by erythropoietin requires elevated expression of its receptor in neurons","volume":"106","author":"Sanchez","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib90","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.bpa.2010.10.005","article-title":"Erythropoietin as neuroprotective and neuroregenerative treatment strategy: comprehensive overview of 12 years of preclinical and clinical research","volume":"24","author":"Sargin","year":"2010","journal-title":"Best Pract. Res. Clin. Anaesthesiol"},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib91","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1741-7007-9-27","article-title":"Expression of constitutively active erythropoietin receptor in pyramidal neurons of cortex and hippocampus boosts higher cognitive functions in mice","volume":"9","author":"Sargin","year":"2011","journal-title":"BMC Biol."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib92","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1440-1681.1999.02986.x","article-title":"Barrier mechanisms in the brain, I. Adult brain","volume":"26","author":"Saunders","year":"1999","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib93","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.neuroscience.2006.04.059","article-title":"A\u00a0neural cell adhesion molecule-derived fibroblast growth factor receptor agonist, the FGL-peptide, promotes early postnatal sensorimotor development and enhances social memory retention","volume":"141","author":"Secher","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib94","doi-asserted-by":"crossref","first-page":"187","DOI":"10.18632\/aging.100440","article-title":"Prevention of beta-amyloid degeneration of microglia by erythropoietin depends on Wnt1, the PI 3-K\/mTOR pathway, Bad, and Bcl-xL","volume":"4","author":"Shang","year":"2012","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib95","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.neurobiolaging.2008.05.015","article-title":"Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain","volume":"31","author":"Simpson","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib96","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1073\/pnas.051606598","article-title":"Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress","volume":"98","author":"Siren","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib97","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.nurt.2008.10.041","article-title":"Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system","volume":"6","author":"Siren","year":"2009","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib98","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.braindev.2011.05.002","article-title":"Neuroprotective effects of recombinant human erythropoietin in the developing brain of rat after lithium-pilocarpine induced status epilepticus","volume":"34","author":"Sozmen","year":"2012","journal-title":"Brain Dev."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib99","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1203\/pdr.0b013e31805341dc","article-title":"Pharmacokinetics of high-dose recombinant erythropoietin in plasma and brain of neonatal rats","volume":"61","author":"Statler","year":"2007","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib100","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1002\/jnr.21745","article-title":"Protective effects of erythropoietin on tau phosphorylation induced by beta-amyloid","volume":"86","author":"Sun","year":"2008","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib101","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/26773","article-title":"Efficiency of signalling through cytokine receptors depends critically on receptor orientation","volume":"395","author":"Syed","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib102","doi-asserted-by":"crossref","first-page":"869269","DOI":"10.1155\/2014\/869269","article-title":"Drug delivery systems, CNS protection, and the blood brain barrier","volume":"2014","author":"Upadhyay","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib103","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1016\/j.lfs.2005.10.027","article-title":"Erythropoietin prevents the increase in blood-brain barrier permeability during pentylentetrazol induced seizures","volume":"78","author":"Uzum","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib104","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuron.2004.09.010","article-title":"Deciphering the molecular basis of memory failure in Alzheimer's disease","volume":"44","author":"Walsh","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib105","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s13311-015-0418-y","article-title":"Beneficial effect of erythropoietin short peptide on acute traumatic brain injury","volume":"13","author":"Wang","year":"2016","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib106","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00228-005-0896-7","article-title":"The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin","volume":"61","author":"Xenocostas","year":"2005","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib107","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3171\/2009.9.JNS09844","article-title":"Delayed administration of erythropoietin reducing hippocampal cell loss, enhancing angiogenesis and neurogenesis, and improving functional outcome following traumatic brain injury in rats: comparison of treatment with single and triple dose","volume":"113","author":"Xiong","year":"2009","journal-title":"J.\u00a0Neurosurg."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib108","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1242\/dev.129.2.505","article-title":"Erythropoietin receptor signalling is required for normal brain development","volume":"129","author":"Yu","year":"2002","journal-title":"Development"},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib109","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.eplepsyres.2011.06.009","article-title":"Impact of the erythropoietin-derived peptide mimetic Epotris on the histopathological consequences of status epilepticus","volume":"96","author":"Zellinger","year":"2011","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2019.01.066","article-title":"MEPO promotes neurogenesis and angiogenesis but suppresses gliogenesis in mice with acute ischemic stroke","volume":"849","author":"Zhang","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neurobiolaging.2019.05.003_bib111","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ajpath.2011.03.021","article-title":"Time-course and regional analyses of the physiopathological changes induced after cerebral injection of an amyloid beta fragment in rats","volume":"179","author":"Zussy","year":"2011","journal-title":"Am. J. Pathol."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458019301381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458019301381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:30:25Z","timestamp":1759318225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458019301381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":111,"alternative-id":["S0197458019301381"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.05.003","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short erythropoietin-derived peptide enhances memory, improves long-term potentiation, and counteracts amyloid beta\u2013induced pathology","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}